Evidence map›Paper›PMID 38261372›Full record

ArticleJMIR formative research2024

Experiences Among Patients With Cystic Fibrosis in the MucoExocet Study of Using Connected Devices for the Management of Pulmonary Exacerbations: Grounded Theory Qualitative Research.

Maxime Morsa, Amélie Perrin, Valérie David, Gilles Rault, Enora Le Roux, Corinne Alberti, Rémi Gagnayre, Dominique Pougheon Bertrand

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JMIR formative research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03304028 (Use of Home-based Connected Devices to Early Detect and Treat Pulmonary Exacerbations), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03304028 naterminatednot on this map

Use of Home-based Connected Devices to Early Detect and Treat Pulmonary Exacerbations: Feasibility and Clinical Validity in CF Patients

TypeinterventionalSponsorInstitut National de la Santé Et de la Recherche Médicale, FranceRan2017 to 2020Enrolled36ConditionsCystic FibrosisArmsConnected Devices for 3 months, Educationnal Intervention, Connected Devices for 12 months, Interviews, Refusal Questionnaires
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Maxime MorsaAdaptation, Resilience and Change Research Unit, University of Liège, Liège, Belgium.ORCID https://orcid.org/0000-0003-2474-6395
Amélie PerrinPaediatrics CF Centre, Nantes University Hospital, Nantes, France.ORCID https://orcid.org/0000-0002-8922-5972
Valérie DavidPaediatrics CF Centre, Nantes University Hospital, Nantes, France.ORCID https://orcid.org/0000-0003-1995-5651
Gilles RaultLaboratoire Educations et Pormotion de la santé, Université Sorbonne Paris Nord, Bobigny, France.ORCID https://orcid.org/0000-0003-1901-7059
Enora Le RouxInstitut National de la Santé et de la Recherche Médicale (UMR 1123 ECEVE), Université de Paris, Paris, France.ORCID https://orcid.org/0000-0002-2238-7133
Corinne AlbertiInstitut National de la Santé et de la Recherche Médicale (UMR 1123 ECEVE), Université de Paris, Paris, France.ORCID https://orcid.org/0000-0002-9336-1395
Rémi GagnayreLaboratory Health Promotion and Education (UR3412), Sorbonne Paris North University, Bobigny, France.ORCID https://orcid.org/0000-0002-8942-9713
Dominique Pougheon BertrandLaboratory Health Promotion and Education (UR3412), Sorbonne Paris North University, Bobigny, France.ORCID https://orcid.org/0000-0002-1241-2753
Inserm · FRUniversité Sorbonne Paris Nord · FRSorbonne Université · FRUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly detection of pulmonary exacerbations (PEx) in patients with cystic fibrosis is important to quickly trigger treatment and reduce respiratory damage. An intervention was designed in the frame of the MucoExocet research study providing patients with cystic fibrosis with connected devices and educating them to detect and react to their early signs of PEx.

objectiveThis study aims to identify the contributions and conditions of home monitoring in relation to their care teams from the users' point of view to detect PEx early and treat it. This study focused on the patients' experiences as the first and main users of home monitoring.

methodsA qualitative study was conducted to explore patients' and professionals' experiences with the intervention. We interviewed patients who completed the 2-year study using semistructured guides and conducted focus groups with the care teams. All the interviews were recorded and transcribed verbatim. Their educational material was collected. A grounded analysis was conducted by 2 researchers.

resultsA total of 20 patients completed the study. Three main categories emerged from the patients' verbatim transcripts and were also found in those of the professionals: (1) task technology fit, reflecting reliability, ease of use, accuracy of data, and support of the technology; (2) patient empowerment through technology, grouping patients' learnings, validation of their perception of exacerbation, assessment of treatment efficacy, awareness of healthy behaviors, and ability to react to PEx signs in relation to their care team; (3) use, reflecting a continuous or intermittent use, the perceived usefulness balanced with cumbersome measurements, routinization and personalization of the measurement process, and the way data are shared with the care team. Furthermore, 3 relationships were highlighted between the categories that reflect the necessary conditions for patient empowerment through the use of technology.

conclusionsWe discuss a theorization of the process of patient empowerment through the use of connected devices and call for further research to verify or amend it in the context of other technologies, illnesses, and care organizations.

trial registrationClinicalTrials.gov NCT03304028; https://clinicaltrials.gov/ct2/show/results/NCT03304028.

Indexed as

carechronic diseasecystic fibrosisdetectiondeviceseducationempowermentmHealthmobile healthmonitoringpatient educationpatientsrespiratorytreatment

Identifiers

PMID38261372
PMCPMC10848132
OpenAlexW4312262433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.